This is an aptamer development services to screening aptamers binds to the BACE2 with an affinity of 1nM~1μM.
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Target Category | Protein |
Target | BACE2 |
Alternative Names | Beta-Secretase 2; ALP56; DRAP; Membrane-Associated Aspartic Protease 1; Beta-Site APP-Cleaving Enzyme 2; Aspartyl Protease 1; Theta-Secretase; Memapsin-1; AEPLC; ASP21; CEAP1; ASP1; Beta-Site Amyloid Beta A4 Precursor Protein-Cleaving Enzyme 2; Beta-Site Amyloid Precursor Protein Cleaving Enzyme 2; Down Syndrome Region Aspartic Protease; Transmembrane Aspartic Proteinase Asp1; Beta-Site APP Cleaving Enzyme 2; 56 KDa Aspartic-Like Protease; Aspartic-Like Protease 56 KDa; Down Region Aspartic Protease; SLCO3A1/BACE2 Fusion; EC 3.4.23.45; Memapsin 1; EC 3.4.23; CDA13; BACE2; Asp 1; BAE2 |
Gene ID | 25825 |
UniProt ID | Q9Y5Z0 |
Target Overview | This gene encodes an integral membrane glycoprotein that functions as an aspartic protease. The encoded protein cleaves amyloid precursor protein into amyloid beta peptide, which is a critical step in the etiology of Alzheimer's disease and Down syndrome. The protein precursor is further processed into an active mature peptide. Alternative splicing results in multiple transcript variants. |
Chemical Modification | N/A |
Type | DNA |
Length | 20-80 nt |
Affinity (Kd) | 1nM~1μM |
Binding Conditions/Buffer | PBS; buffer system with Serum; other |